CYP2C19 polymorphisms
Showing 1 - 25 of >10,000
Safety and Efficacy of Voriconazole
Unknown status
- Adverse Drug Reactions
-
İzmir, TurkeyDokuz Eylul University Hospital
Sep 14, 2020
Liver Metabolizing Enzyme in Taiwanese Patients
Completed
- Invasive Fungal Infections
- Blood drawn (lab data)
-
Taipei, TaiwanNational Taiwan University Hospital
Feb 8, 2022
CYP1A2, ABCB1, CYP2C9 and Plasma Concentration of Agomelatine in
Not yet recruiting
- Polymorphism, Genetic
- +5 more
- (no location specified)
Nov 3, 2023
Atrial Fibrillation, Coronary Artery Disease Trial (Rivaroxaban)
Not yet recruiting
- Atrial Fibrillation
- Coronary Artery Disease
- (no location specified)
Oct 22, 2023
CYP2C19 Genetic Variants Trial in Stanford (Limonene)
Recruiting
- CYP2C19 Genetic Variants
- Limonene
-
Stanford, CaliforniaStanford School of Medicine
Aug 18, 2022
Healthy Trial (Voriconazole 200mg, FluvoxaMINE 50 Mg Oral Tablet, Omeprazole 10 MG Oral Tablet)
Not yet recruiting
- Healthy
- Voriconazole 200mg
- +2 more
- (no location specified)
Feb 21, 2022
Rheumatoid Arthritis Trial in Wuhan (SHR0302 Tablets, Midazolam Maleate Tablets, Warfarin Sodium Tablets)
Completed
- Rheumatoid Arthritis
- SHR0302 Tablets
- +5 more
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Dec 21, 2022
Blood Vessel Study
Completed
- Cardiovascular Disease
-
Research Triangle Park, North CarolinaNIEHS Clinical Research Unit (CRU)
Jan 25, 2023
Coronary Artery Disease, Platelet Reactivity Trial (CYP2C19 genotype guided P2Y12 monotherapy, Clopidogrel)
Not yet recruiting
- Coronary Artery Disease
- Platelet Reactivity
- CYP2C19 genotype guided P2Y12 monotherapy
- Clopidogrel
- (no location specified)
Mar 7, 2023
Acute Coronary Syndrome, CYP2C19 Polymorphism Trial in Nieuwegein (Clopidogrel)
Recruiting
- Acute Coronary Syndrome
- CYP2C19 Polymorphism
-
Nieuwegein, Utrecht, NetherlandsSt. Antonius Hospital
Jun 27, 2023
COPD Trial in Kashgar (Theophylline)
Completed
- Chronic Obstructive Pulmonary Disease
-
Kashgar, Xinjiang, ChinaKashgar 1st People's Hospital
Mar 2, 2022
Ischemic Stroke, Transient Ischemic Attack Trial in Singapore (Genetic testing)
Not yet recruiting
- Ischemic Stroke
- Transient Ischemic Attack
- Genetic testing
-
Singapore, SingaporeSingapore General Hospital
Mar 9, 2023
Obesity, GERD Trial in Kansas City (Pantoprazole)
Completed
- Obesity
- GERD
-
Kansas City, MissouriChildren's Mercy Hospital and Clinics
Oct 26, 2021
Diabetes, Type 2 Trial in Sarajevo (Omeprazole, Placebo oral tablet, Gliclazide)
Completed
- Diabetes Mellitus, Type 2
- Omeprazole
- +2 more
-
Sarajevo, Bosnia and HerzegovinaGeneral Hospital Prim. Dr. Abdulah Nakas
Jul 19, 2021
Mitochondrial Disease Trial in Leeds (KL1333, Flurbiprofen, Dextromethorphan)
Completed
- Mitochondrial Disease
- KL1333
- +7 more
-
Leeds, United KingdomVolunteer recruitment center Covance Leeds Covance Leeds
Oct 19, 2021
CYP2C9*3 Polymorphism on Ibuprofen in Pakistani Population
Completed
- Healthy Volunteers
- Ibuprofen
-
Rawalpindi, Punjab, PakistanAmmarah Amjad
Aug 1, 2023
Drug Interaction Trial in Uppsala (Drug Drug Interaction)
Recruiting
- Drug Interaction
- Drug Drug Interaction
-
Uppsala, SwedenCTC Clinical Trial Consultants AB
Apr 13, 2023
Efficacy of Voriconazole in Pediatric Hematologic Malignancy
Recruiting
- Adverse Drug Reactions
-
İzmir, TurkeyDokuz Eylul University Hospital
Feb 3, 2021
Personalized Antiplatelet Therapy in CAD Patients
Completed
- Coronary Artery Disease
- (no location specified)
Dec 14, 2021
Peripheral Arterial Disease Trial in Netherlands (Direct CYP2C19 genotyping, CYP2C19 genotyping at the end of the study, Poor
Recruiting
- Peripheral Arterial Disease
- Direct CYP2C19 genotyping
- +4 more
-
Apeldoorn, Netherlands
- +10 more
Apr 19, 2022
Relapsed or Refractory Lymphoma Trial in Miami (Itraconazole 200 mg, Fluconazole 400 mg, Rifampin 600 mg)
Completed
- Relapsed or Refractory Lymphoma
- Itraconazole 200 mg
- +3 more
-
Miami, FloridaQPS- Miami
Jan 12, 2023